| Name | Title | Contact Details |
|---|
Columbus Mckinnon is a New York-based company that manufactures and distributes material handling products including hoists and cranes for sectors such as food and utilities.
Progress is achieved by those with the courage to reimagine whats possible. Audi was born more than a century ago with a vision of boldly challenging the status quo and is bound by a promise to imaginatively innovate. We believe the best ideas—the ideas that will define our future—will come from new ways of thinking. We believe everyone should have a voice. We believe in equality. We believe that "we" includes all of us. For these reasons, we strive to create a workplace where diverse ideas are embraced, where people can be themselves, and where everyone comes together to reinvent mobility, drive toward a more sustainable future and create amazing customer experiences.
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.
CIDAN Machinery Group is a leading manufacturer of sheet metal processing machinery, with a history that dates back to 1907. Originating from Göteneds Mekaniska Verkstad in Sweden, the company has expanded globally through mergers and acquisitions, including the acquisition of CIDAN A/S in Denmark. Today, CIDAN operates in multiple countries, including Sweden, Austria, Switzerland, China, Denmark, and the United States, serving customers in over 52 countries through a network of 61 dealers. The company offers a wide range of machinery for sheet metal working, including power folders, mechanical shears, cut-to-length lines, and CNC-controlled brakes. Their products are known for quality and precision, marketed under brand names such as CIDAN, Göteneds, Thalmann, and Forstner. CIDAN emphasizes innovation and user-friendly design, providing solutions that support Industry 4.0 and automation trends. Their dedicated sales and support teams assist customers with shop layout and process optimization, ensuring comprehensive service. CIDAN Machinery Group serves a diverse customer base, including sheet metal shops and manufacturing companies, contributing to various industries worldwide.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.